Long-term follow-up for tongue swallowing study
Part of Digestive system, Ear, nose & throat clinical trials.
This study checks how well people with tongue-related swallowing problems do over the long term, and whether a treatment called iltamiocel continues to help. It is only for people who have already completed the REVIVE study and received the real treatment, not a placebo.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have completed the main REVIVE study, including the 24-month visit.
- You received the actual treatment (iltamiocel) during the study, not a placebo.
- You are willing to join and follow the study's procedures, and you can give your consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special therapy to help people who have trouble swallowing after treatment for head and neck cancer. It aims to improve quality of life by using exercises and strategies to make eating and drinking safer and more comfortable.
This trial tests a new way to measure how well your throat and voice box work during swallowing. It may help doctors better understand swallowing problems and improve care.
This study tests if using a device to exercise your tongue after partial tongue removal helps you recover tongue strength and function better than standard care. It is for people having their first surgery for oral tongue cancer.
This study tests a non-invasive brain stimulation method to help people who have trouble swallowing after a stroke. It aims to see if this treatment can improve swallowing function during recovery.
This trial tests whether starting speech and swallowing therapy early after surgery helps people with tongue cancer recover their ability to eat and talk. It is for patients having part of their tongue removed and rebuilt with a tissue flap.
This trial tests whether giving radiation after surgery can lower the risk of the cancer coming back for people with oral tongue cancer that has specific high-risk features but not advanced spread. It aims to find the best treatment plan for patients with certain tumor characteristics.
Hear when a new Oropharyngeal Dysphagia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.